Medication Management Initiatives Using Wearable Devices: Scoping Review

Overview

Journal JMIR Hum Factors

Specialty Health Services

Date 2024 Nov 27

PMID 39602520

Authors

Haru Iino

Hayato Kizaki

Shungo Imai

Satoko Hori

Affiliations

Soon will be listed here.

Abstract

Background: Wearable devices (WDs) have evolved beyond simple fitness trackers to sophisticated health monitors capable of measuring vital signs, such as heart rate and blood oxygen levels. Their application in health care, particularly medication management, is an emerging field poised to significantly enhance patient adherence to treatment regimens. Despite their widespread use and increasing incorporation into clinical trials, a comprehensive review of WDs in terms of medication adherence has not been conducted.

Objective: This study aimed to conduct a comprehensive scoping review to evaluate the impact of WDs on medication adherence across a variety of diseases, summarizing key research findings, outcomes, and challenges encountered.

Methods: Adhering to PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) guidelines, a structured search was conducted across MEDLINE, Web of Science, and Embase databases, covering the literature from January 1, 2010, to September 30, 2022. The search strategy was based on terms related to WDs and medication adherence, specifically focusing on empirical studies to ensure the inclusion of original research findings. Studies were selected based on their relevance to medication adherence, usage of WDs in detecting medication-taking actions, and their role in integrated medication management systems.

Results: We screened 657 articles and identified 18 articles. The identified studies demonstrated the diverse applications of WDs in enhancing medication adherence across diseases such as Parkinson disease, diabetes, and cardiovascular conditions. The geographical distribution and publication years of these studies indicate a growing interest in this research area. The studies were divided into three types: (1) studies reporting a correlation between data from WDs or their usage and medication adherence or drug usage as outcomes, (2) studies using WDs to detect the act of medication-taking itself, and (3) studies proposing an integrated medication management system that uses WDs in managing medication.

Conclusions: WDs are increasingly being recognized for their potential to enhance medication management and adherence. This review underscores the need for further empirical research to validate the effectiveness of WDs in real-life settings and explore their use in predicting adherence based on activity rhythms and activities. Despite technological advancements, challenges remain regarding the integration of WDs into routine clinical practice. Future research should focus on leveraging the comprehensive data provided by WDs to develop personalized medication management strategies that can improve patient outcomes.

References

Vrijens B, de Geest S, Hughes D, Przemyslaw K, Demonceau J, Ruppar T . A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012; 73(5):691-705. PMC: 3403197. DOI: 10.1111/j.1365-2125.2012.04167.x. View

Sempionatto J, Lasalde-Ramirez J, Mahato K, Wang J, Gao W . Wearable chemical sensors for biomarker discovery in the omics era. Nat Rev Chem. 2023; 6(12):899-915. PMC: 9666953. DOI: 10.1038/s41570-022-00439-w. View

Fozoonmayeh D, Le H, Wittfoth E, Geng C, Ha N, Wang J . A Scalable Smartwatch-Based Medication Intake Detection System Using Distributed Machine Learning. J Med Syst. 2020; 44(4):76. DOI: 10.1007/s10916-019-1518-8. View

Zhang Y, Yang N, Si G, Zhang Y, Dong Z, Huang Y . What matters the adherence with BP 24-hr self-monitoring wearable device among hypertensive patients? A population-based survey. Transl Behav Med. 2019; 10(4):1053-1063. DOI: 10.1093/tbm/ibz069. View

da Silva V, da Silva Souza V, Guimaraes da Cruz R, de Lucena J, Jazdi N, Ferreira de Lucena Junior V . Commercial Devices-Based System Designed to Improve the Treatment Adherence of Hypertensive Patients. Sensors (Basel). 2019; 19(20). PMC: 6832274. DOI: 10.3390/s19204539. View

Silva de Lima A, Evers L, Hahn T, Bataille L, Hamilton J, Little M . Freezing of gait and fall detection in Parkinson's disease using wearable sensors: a systematic review. J Neurol. 2017; 264(8):1642-1654. PMC: 5533840. DOI: 10.1007/s00415-017-8424-0. View

Bayoumy K, Gaber M, Elshafeey A, Mhaimeed O, Dineen E, Marvel F . Smart wearable devices in cardiovascular care: where we are and how to move forward. Nat Rev Cardiol. 2021; 18(8):581-599. PMC: 7931503. DOI: 10.1038/s41569-021-00522-7. View

Cochran J, Fang H, Gallo C, Peters-Strickland T, Lindenmayer J, Reuteman-Fowler J . Participant Engagement and Symptom Improvement: Aripiprazole Tablets with Sensor for the Treatment of Schizophrenia. Patient Prefer Adherence. 2022; 16:1805-1817. PMC: 9342879. DOI: 10.2147/PPA.S362889. View

Levine D, Torabi J, Choinski K, Rocca J, Graham J . Transplant surgery enters a new era: Increasing immunosuppressive medication adherence through mobile apps and smart watches. Am J Surg. 2019; 218(1):18-20. DOI: 10.1016/j.amjsurg.2019.02.018. View

10.

Bent B, Cho P, Henriquez M, Wittmann A, Thacker C, Feinglos M . Engineering digital biomarkers of interstitial glucose from noninvasive smartwatches. NPJ Digit Med. 2021; 4(1):89. PMC: 8172541. DOI: 10.1038/s41746-021-00465-w. View

11.

Conn V, Ruppar T . Medication adherence outcomes of 771 intervention trials: Systematic review and meta-analysis. Prev Med. 2017; 99:269-276. PMC: 5467216. DOI: 10.1016/j.ypmed.2017.03.008. View

12.

Ahmed I, Ahmad N, Ali S, Ali S, George A, Saleem Danish H . Medication Adherence Apps: Review and Content Analysis. JMIR Mhealth Uhealth. 2018; 6(3):e62. PMC: 5878368. DOI: 10.2196/mhealth.6432. View

13.

Arakawa T . Recent Research and Developing Trends of Wearable Sensors for Detecting Blood Pressure. Sensors (Basel). 2018; 18(9). PMC: 6165193. DOI: 10.3390/s18092772. View

14.

Lee H, Hong Y, Baik S, Hyeon T, Kim D . Enzyme-Based Glucose Sensor: From Invasive to Wearable Device. Adv Healthc Mater. 2018; 7(8):e1701150. DOI: 10.1002/adhm.201701150. View

15.

Mattison G, Canfell O, Forrester D, Dobbins C, Smith D, Toyras J . The Influence of Wearables on Health Care Outcomes in Chronic Disease: Systematic Review. J Med Internet Res. 2022; 24(7):e36690. PMC: 9288104. DOI: 10.2196/36690. View

16.

Islam S, Mishra V, Siddiqui M, Chandir Moses J, Adibi S, Nguyen L . Smartphone Apps for Diabetes Medication Adherence: Systematic Review. JMIR Diabetes. 2022; 7(2):e33264. PMC: 9257622. DOI: 10.2196/33264. View

17.

Daar E, Rosen M, Wang Y, Siqueiros L, Shen J, Guerrero M . Real-Time and Wireless Assessment of Adherence to Antiretroviral Therapy With Co-Encapsulated Ingestion Sensor in HIV-Infected Patients: A Pilot Study. Clin Transl Sci. 2019; 13(1):189-194. PMC: 6951462. DOI: 10.1111/cts.12701. View

18.

Belknap R, Weis S, Brookens A, Au-Yeung K, Moon G, DiCarlo L . Feasibility of an ingestible sensor-based system for monitoring adherence to tuberculosis therapy. PLoS One. 2013; 8(1):e53373. PMC: 3538759. DOI: 10.1371/journal.pone.0053373. View

19.

Han M, Lee Y, Park T, Ihm S, Pyun W, Burkard T . Feasibility and measurement stability of smartwatch-based cuffless blood pressure monitoring: A real-world prospective observational study. Hypertens Res. 2023; 46(4):922-931. DOI: 10.1038/s41440-023-01215-z. View

20.

Chakrabarti S . What's in a name? Compliance, adherence and concordance in chronic psychiatric disorders. World J Psychiatry. 2014; 4(2):30-6. PMC: 4087153. DOI: 10.5498/wjp.v4.i2.30. View